Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00364104 · ClinicalTrials.gov registry record · Phase 3
Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children
A Phase 3 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 3
- Development phase
- 125
- Enrollment target
NCT00364104 is a Phase 3 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 125 participants.
The verdict
NCT00364104, a Phase 3 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 125 participants
- Enrollment target
Study Summary
The investigators hypothesize that the Helicobacter pylori bacterium decreases iron from the stomach and that this effect of the infection can be identified among persons with iron deficiency as well as among persons with normal iron stores. The aim of this study is to determine whether Helicobacter pylori eradication in children is followed by an increase in markers of iron stores after six to twelve months of treatment.
Interventions
- DRUG Placebo
- DRUG Ferrous sulfate
- DRUG Quadruple sequential Helicobacter pylori eradication + iron sulfate
- DRUG Quadruple sequential Helicobacter pylori eradication therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00364104
The ClinicalTrials.gov registry entry for NCT00364104 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT00364104 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00364104 about?
NCT00364104 is a clinical study titled "Helicobacter Pylori Eradication Trial to Reduce Iron Deficiency in Children". The investigators hypothesize that the Helicobacter pylori bacterium decreases iron from the stomach and that this effect of the infection can be identified among persons with iron deficiency as well as among persons with normal iron stores. The aim of this study is to determine whether Helicobacter...
What is the current status of trial NCT00364104?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 125 participants. The study started on 2007-03. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00364104?
The interventions under investigation include: Placebo (DRUG), Ferrous sulfate (DRUG), Quadruple sequential Helicobacter pylori eradication + iron sulfate (DRUG), Quadruple sequential Helicobacter pylori eradication therapy (DRUG).
Who is sponsoring clinical trial NCT00364104?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.